Interleukin-3-treated non-B, non-T cells switch activated B cells to IgG1/IgE synthesis
- 1 November 1992
- journal article
- Published by Wiley in European Journal of Immunology
- Vol. 22 (11) , 2783-2787
- https://doi.org/10.1002/eji.1830221105
Abstract
No abstract availableKeywords
This publication has 21 references indexed in Scilit:
- A sensitive and efficient induction system for murine IgE single cell analysis at the clonal levelJournal of Immunological Methods, 1991
- Infection with Nippostrongylus brasiliensis or injection of anti-IgD antibodies markedly enhances Fc-receptor-mediated interleukin 4 production by non-B, non-T cells.The Journal of Experimental Medicine, 1990
- Cross-linking Fc receptors stimulate splenic non-B, non-T cells to secrete interleukin 4 and other lymphokines.Proceedings of the National Academy of Sciences, 1990
- Pleiotropy and redundancy: T cell-derived lymphokines in the immune responseCell, 1989
- Production of the haemopoietic growth factors GM-CSF and interleukin-3 by mast cells in response to IgE receptor-mediated activationNature, 1989
- Mast cell lines produce lymphokines in response to cross-linkage of FcεRI or to calcium ionophoresNature, 1989
- Interleukin 4 instructs uncommitted B lymphocytes to switch to IgGl and IgEEuropean Journal of Immunology, 1988
- Structure and Function of Human and Murine Receptors for IgGAnnual Review of Immunology, 1988
- Suppression of in vivo polyclonal IgE responses by monoclonal antibody to the lymphokine B-cell stimulatory factor 1.Proceedings of the National Academy of Sciences, 1986
- A severe combined immunodeficiency mutation in the mouseNature, 1983